Patent Law Trumps Policy In Myriad Cancer Gene Decision
The Federal Circuit's Thursday ruling affirming the validity of breast cancer genes isolated by Myriad Genetics Inc. makes clear that the court's decision on whether an invention is eligible for a...To view the full article, register now.
Already a subscriber? Click here to view full article